DACED

ANNUAL CONFERENCE

The German Association for Chronic Inflammatory Bowel Diseases (DACED) is a working group of the German Society for Digestive and Metabolic Diseases (DGVS)

Upcoming events

DACED serves the scientific exchange within basic science and clinical research in the field of IBD. The aim is to find causes of IBD and to improve the treatment of patients through coordinated and targeted research.
There is a close collaboration with the Competence Network on Intestinal Diseases (Kompetenznetz Darmerkrankungen) as well as with the German IBD Study Group. Since 2011, the German representatives of the European Crohn’s- and Colitis Organization (ECCO) have been elected together with the Competence Network Intestinal Diseases.
Since 2014, DACED has been integrated into the Competence Network for Intestinal Diseases. Accordingly, it provides two members in the board of the competence network. With the integration of the DACED, the non-clinical IBD research landscape is included in the competence network and thus the topic „IBD“ is represented in Germany across all areas by the competence network. The aim of the cooperation agreement is to support experimental and clinical work in the field of inflammatory bowel diseases across the network boundaries to strengthen research and to improve the care of IBD sufferers.

Deutsch

Die DACED dient dem wissenschaftlichen Austausch in der grundlagenwissenschaftlichen und klinischen Forschung auf dem Gebiet der CED. Ziel ist es, durch koordinierte und gezielte Forschung die Ursachen von CED zu erforschen und die Behandlung der Patient:innen zu verbessern.

Es besteht eine enge Zusammenarbeit mit dem Kompetenznetz Darmerkrankungen sowie mit der Deutschen IBD-Studiengruppe. Seit 2011 werden gemeinsam mit dem Kompetenznetz Darmerkrankungen die deutschen Vertreter:innen in der European Crohn’s- and Colitis Organization (ECCO) gewählt.

Seit 2014 ist die DACED in das Kompetenznetz Darmerkrankungen integriert. Entsprechend stellt es ein bis zwei Mitglieder im Vorstand des Kompetenznetzes. Mit der Integration des DACED wird die nichtklinische IBD-Forschungslandschaft in das Kompetenznetz einbezogen und somit das Thema „IBD“ in Deutschland über alle Bereiche hinweg durch das Kompetenznetz vertreten. Ziel der Kooperationsvereinbarung ist es, experimentelle und klinische Arbeiten auf dem Gebiet der chronisch entzündlichen Darmerkrankungen über die Netzwerkgrenzen hinaus zu unterstützen, um die Forschung zu stärken und die Versorgung von IBD-Betroffenen zu verbessern.

Vorabend-Symposium zur DACED
_{Kompetenznetz Darmerkrankungen}

Information follow

DACED Annual Conference 2026

Although the event is free of charge, attendees participating during regular working hours may require prior approval from their employer. Please check your organization’s internal policies regarding working time and professional development. A downloadable employer authorization form is available below and can be completed and returned to the following email address: daced@kompetenznetz-darmerkrankungen.de

Board Member 2026

Dr. med. Miriam Wiestler

Former Board Members


2025	Prof. Dr. med. Dr. rer. nat. Ahmed N. Hegazy
2024	Prof. Dr. rer. nat. Claudia Günther, Prof. Dr. med. Irina Blumenstein
2023	Prof. Dr. med. Florian Tran

Prior to 2023


2022	Prof. Dr. med. Raja Atreya, Prof. Dr. med. Michael Scharl
2021	PD Dr. med. Michael Schumann
2019	Prof. Dr. med. Dominik Bettenworth, Prof. Dr. med. Samuel Huber
2018	Prof. Dr. med. Konrad Aden
2017	Prof. Dr. med. Sebastian Zeißig
2016	Prof. Dr. med. Anne Krug, PD Dr. med. Wolfgang Reindl
2015	Prof. Dr. med. Jonas Mudter, Prof. Dr. med. Clemens Neufert Ph.D.
2014	Prof. Dr. med. Jürgen Büning, Prof. Dr. med. Christian Sina
2013	Prof. Dr. med. Oliver Bachmann
2012	Prof. Dr. med. Christian Maaser
2011	Prof. Dr. med. Jan Wehkamp
2010	Prof. Dr. med. Tanja Kühbacher, Prof. Dr. med. Susanna Nikolaus

DACED FUTURE AWARD
The DACED – German Working Group for Chronic Inflammatory Bowel Diseases – awards the DACED Future Award at its annual congress. The prize recognizes outstanding experimental or clinical research in the field of chronic inflammatory bowel diseases and was endowed by FERRING Arzneimittel GmbH. Below you will find the corresponding press releases.